Status | Study |
Withdrawn |
Study Name: BRILLIANT-SC: A Study of the Efficacy and Safety of Blisibimod Administration in Subjects With IgA Nephropathy Condition: IgA Nephropathy Date: 2014-01-29 Interventions: Drug: Blisibimod Blisibimod ad |
Completed |
Study Name: IgA Nephropathy, Lymphocyte Homing and IgA Class Switch Condition: IgA Nephropathy Date: 2013-01-18 Interventions: Other: blood test |
Active, not recruiting |
Study Name: Treatment of Prednisone Plus Cyclophosphamide in Patients With Advanced-stage IgA Nephropathy Condition: IgA Nephropathy Date: 2012-12-12 Interventions: Drug: prednisone plus cyclophosphamide |
Completed |
Study Name: A Survey of Factors Affecting an Early or Delayed Diagnosis of IgA Nephropathy Condition: IgA Nephropathy Date: 2012-02-19 |
Completed |
Study Name: An Observational Study of IgA Nephropathy: Pathological Variants and Clinical Data Condition: IgA Nephropathy Date: 2011-12-29 |
Terminated |
Study Name: Diet Intervention in Food Sensitive Patients With IgA Nephropathy Condition: IGA Nephropathy Date: 2010-09-15 Interventions: Dietary Supplement: Tailored diet |
Not yet recruiting |
Study Name: A Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA Nephropathy Condition: Glomerulonephritis, IGA Hypertension Date: 2010-08-16 Interventions: Drug: aliskiren 150 mg/day p.o. |
Completed |
Study Name: Mycophenolate Mofetil for IgA Nephropathy Condition: IGA Nephropathy Date: 2009-03-15 Interventions: Drug: mycophenolate mofetil Or |
Completed |
Study Name: A Controlled Study of Uric Acid on the Progression of IgA Nephropathy Condition: IgA Nephropathy Date: 2008-11-17 Interventions: Drug: allopurinol Patients wil |
Active, not recruiting |
Study Name: Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN) Condition: IgA Nephropathy Date: 2008-04-08 Interventions: Drug: irbesartan In the ARB le |